This article was reviewed by Darragh O’Carroll, MD. Key Takeaways: You can get semaglutide injections (Ozempic® and Wegovy®) and oral semaglutide (Rybelsus®). Injections are usually more ...

In patients with type 2 diabetes and heart failure, those assigned oral semaglutide had reduced risk for heart failure events ...

Researchers find that repeated SNAC exposure altered gut bacteria and increased inflammatory markers in an animal study. While this does not show that SNAC directly causes harm, it highlights an ...

Hims & Hers Health, Inc. faces volatile earnings as compounded GLP-1 setbacks pressure shares. Click for this HIMS stock earnings preview.

Oral semaglutide lowers heart failure events in people with type 2 diabetes and existing heart failure without increasing ...

Novo Nordisk (CPSE:NOVO B) has used legal and regulatory pressure to push Hims & Hers to drop plans for a compounded oral ...

Blockbuster weight-loss drugs are transforming the way we treat obesity. But while costly injectable versions remain out of ...

GoodRx reports that the FDA has approved oral semaglutide (Wegovy) for weight loss, offering an alternative to injections with similar results.

Novo Nordisk addresses deceptive advertising by Hims & Hers regarding unapproved GLP-1 products as oral Wegovy remains in full supply in the US.

In A Nutshell A new animal study found that SNAC, the absorption-boosting additive in Rybelsus (oral semaglutide), was linked to significant reductions in gut bacteria associated with fiber ...

A new study from Adelaide University is turning a spotlight on those tablet versions, finding that the absorption-enhancing ingredient salcaprozate sodium (SNAC) may have measurable adverse biological ...

The intake of oral semaglutides such as Wegovy or Rybelsus among adults with type 2 diabetes (T2D) was associated with a reduced risk of heart failure (HF) compared to those who took a placebo, ...